[Protective effect of DNA-spermidine (DA-51) against radiation-induced leukopenia. (Preliminary report)--a study on breast cancer patients receiving prophylactic irradiation (author's transl)].
D001943:Breast Neoplasms / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D004247:DNA / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000517:prevention & control*; D011832:Radiation Injuries / Q000517:prevention & control*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D013095:Spermidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D011837:Radiation-Protective Agents; C007545:DNA-spermidine; D004247:DNA; D013095:Spermidine